Article

Research advances in immunotherapy combined with DNA damage response inhibitors for liver cancer therapy

2024-01-01

Abstract excerpt

Cancer immunotherapy utilizes checkpoint inhibitors to amplify the antitumor immune response. The DNA damage repair system plays a crucial role in preserving genome stability, offering therapeutic avenues for tumor treatment by impeding the DNA damage repair pathway. In cancer immunotherapy, checkpoint inhibitors are used to enhance the antitumor immune response. The DNA damage response (DDR) and immune response a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 89751d92-a20d-5a81-a283-8952da3e963d
DOI: 10.20517/2394-4722.2023.175

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Research advances in immunotherapy combined with DNA damage response inhibitors for liver cancer therapyDOI 10.20517/2394-4722.2023.175Read

Targeting DNA Damage Response and Repair Genes to Enhance Anticancer Immunotherapy: Rationale and Clinical ImplicationSemantic proximity Read

Involvement of DNA Damage Response Pathways in Hepatocellular CarcinomaSemantic proximity Read

Targeting DNA Damage Repair for Immune Checkpoint Inhibition: Mechanisms and Potential Clinical ApplicationsSemantic proximity Read

Advances in DNA damage response inhibitors in colorectal cancer therapySemantic proximity Read

The role of DNA damage repair (DDR) system in response to immune checkpoint inhibitor (ICI) therapySemantic proximity Read

Radiation-induced liver disease: beyond DNA damageSemantic proximity Read

DNA Damage Repair Profiles Alteration Characterize a Hepatocellular Carcinoma Subtype With Unique Molecular and Clinicopathologic FeaturesSemantic proximity Read

Targeting DNA Damage Response and Immune Checkpoint for Anticancer TherapySemantic proximity Read

Impact of DNA damage response defects in cancer cells on response to immunotherapy and radiotherapy.Semantic proximity Read

Mutations in DNA damage response pathways as a potential biomarker for immune checkpoint blockade efficacy: evidence from a seven-cancer immunotherapy cohort.Semantic proximity Read

Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarksSemantic proximity Read

Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential.Semantic proximity Read